CD133+ niches and single cells in glioblastoma have different phenotypes
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD133+ niches and single cells in glioblastoma have different phenotypes
Authors
Keywords
-
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 104, Issue 1, Pages 129-143
Publisher
Springer Nature
Online
2010-12-24
DOI
10.1007/s11060-010-0488-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2α
- (2010) Sascha Seidel et al. BRAIN
- Endothelial cell transdifferentiation of human glioma stem progenitor cells in vitro
- (2010) Yaodong Zhao et al. BRAIN RESEARCH BULLETIN
- Progress on Antiangiogenic Therapy for Patients with Malignant Glioma
- (2010) Manmeet S. Ahluwalia et al. Journal of Oncology
- Tumor microvasculature supports proliferation and expansion of glioma-propagating cells
- (2009) Tijana Borovski et al. INTERNATIONAL JOURNAL OF CANCER
- Biology of angiogenesis and invasion in glioma
- (2009) Matthew C. Tate et al. Neurotherapeutics
- Evaluation of the Value of Frozen Tissue Section Used as “Gold Standard” for Immunohistochemistry
- (2008) Shan-Rong Shi et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- CD133 Expression and Cancer Stem Cells Predict Prognosis in High-grade Oligodendroglial Tumors
- (2008) Dagmar Beier et al. BRAIN PATHOLOGY
- A Specialized Vascular Niche for Adult Neural Stem Cells
- (2008) Masoud Tavazoie et al. Cell Stem Cell
- Adult SVZ Stem Cells Lie in a Vascular Niche: A Quantitative Analysis of Niche Cell-Cell Interactions
- (2008) Qin Shen et al. Cell Stem Cell
- Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme
- (2008) R. Pallini et al. CLINICAL CANCER RESEARCH
- Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
- (2008) F. Zeppernick et al. CLINICAL CANCER RESEARCH
- Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma
- (2008) Anastasia Murat et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients
- (2008) Mingyu Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Incorporation of endothelial progenitor cells into the neovasculature of malignant glioma xenograft
- (2008) Hua-rong Zhang et al. JOURNAL OF NEURO-ONCOLOGY
- CD133 identifies perivascular niches in grade II–IV astrocytomas
- (2008) Karina Christensen et al. JOURNAL OF NEURO-ONCOLOGY
- Presence of pluripotent CD133+ cells correlates with malignancy of gliomas
- (2008) Niklas Thon et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Glial Progenitor-Like Phenotype in Low-Grade Glioma and Enhanced CD133-Expression and Neuronal Lineage Differentiation Potential in High-Grade Glioma
- (2008) Johan Rebetz et al. PLoS One
- CD133 Is a Marker of Bioenergetic Stress in Human Glioma
- (2008) Corinne E. Griguer et al. PLoS One
- The Cancer Stem Cell–Vascular Niche Complex in Brain Tumor Formation
- (2008) Anand Veeravagu et al. STEM CELLS AND DEVELOPMENT
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started